Drug intelligence / Profile preview

CD34+ stem cell boost

Development stage
Preclinical
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous
01

Overview

A CD34+ stem cell boost is a therapeutic cell therapy procedure involving the infusion of additional hematopoietic stem cells (HSCs) into a patient who has previously undergone an allogeneic hematopoietic cell transplant (HCT) but is experiencing poor graft function or graft failure. The cells are typically enriched for the CD34+ surface marker, which identifies hematopoietic progenitor cells. This boost is often administered without prior conditioning (chemotherapy or radiation), a strategy known as an unconditioned boost, to enhance donor chimerism and improve blood counts without the toxicity associated with a full second transplant. It is primarily utilized as a salvage option in the context of hematologic disorders such as sickle cell disease or following HCT for various malignancies.

Other names
CD34 boostCD-34 boostCD 34 boosthematopoietic stem cell boostHSC boostunconditioned CD34+ boost
02

Targets

SELP (P-selectin)SELE (E-selectin)VEGFR2 (Vascular endothelial growth factor receptor 2)SELL (L-selectin)

Beyond the preview

Go deeper on CD34+ stem cell boost.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD34+ stem cell boost.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call